Montreal, Canada

Richard Lewis Momparler

This inventor holds 4 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., Hopital Sainte-Justine. Active years: 1996-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Lewis Momparler. Retrieved from https://idiyas.com/inventor/richard-lewis-momparler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard Lewis Momparler in Cancer Therapeutics

Introduction

Richard Lewis Momparler, an accomplished inventor located in Montreal, Canada, has made significant strides in the field of biomedicine. With a portfolio of four patents, Momparler's work primarily focuses on gene therapy and cancer treatment, showcasing his expertise and innovative approach to tackling complex medical challenges.

Latest Patents

Among his most notable recent patents is the invention related to "Cytidine deaminase cDNA as a positive selectable marker for gene therapy." This invention involves a DNA sequence for human cytidine deaminase engineered into an eukaryotic expression vector, facilitating its expression in mammalian cells. The expression of cytidine deaminase provides resistance to cytosine nucleoside analogs, including cytosine arabinoside, thereby serving as a positive selectable marker. This advancement not only protects cells from the toxic effects of these analogs but also holds significant therapeutic potential for treating malignant, immune, and viral diseases. Additionally, Momparler's work encompasses methods for inducing inhibition or loss of cell proliferation in solid tumors using various Vitamin D3 analogs and trans retinoic acid, further expanding possibilities in cancer therapy.

Career Highlights

Throughout his esteemed career, Richard Lewis Momparler has worked with leading pharmaceutical and medical institutions, including Hoffmann-La Roche Inc. and Hôpital Sainte-Justine. His expertise in gene therapy and oncology has positioned him as a valuable asset in the field, and his inventions have paved the way for advances in treating challenging diseases.

Collaborations

In his journey, Momparler has collaborated with notable professionals such as Benoit Thomas Dore and Milan R. Uskokovic. These partnerships have enriched his research endeavors and facilitated the sharing of innovative ideas, contributing to the development of groundbreaking therapies.

Conclusion

With his substantial contributions to medical science, Richard Lewis Momparler exemplifies the spirit of innovation and dedication in the pursuit of advancing healthcare. His patents not only highlight his ingenuity as an inventor but also reflect his commitment to improving treatment options for patients suffering from serious illnesses, particularly cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…